|
Oncogenes and Tumor Suppressors
Citations 291-300 of 795 total displayed.
|
Past content
(since May 2000):
|
KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas
- Grzegorz Sarek, Annika Järviluoma, and Päivi M. Ojala
Blood 2006; 107: 725-732.
[Abstract]
[Full text]
[PDF]
Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR
- Kathryn E. Boyd, Ying-Yi Xiao, Kai Fan, Amanda Poholek, Neal G. Copeland, Nancy A. Jenkins, and Archibald S. Perkins
Blood 2006; 107: 733-741.
[Abstract]
[Full text]
[PDF]
PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects
- Karoline V. Gleixner, Matthias Mayerhofer, Karl J. Aichberger, Sophia Derdak, Karoline Sonneck, Alexandra Böhm, Alexander Gruze, Puchit Samorapoompichit, Paul W. Manley, Doriano Fabbro, Winfried F. Pickl, Christian Sillaber, and Peter Valent
Blood 2006; 107: 752-759.
[Abstract]
[Full text]
[PDF]
Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma
- Esther P. M. Tjin, Richard W. J. Groen, Irma Vogelzang, Patrick W. B. Derksen, Melanie D. Klok, Helen P. Meijer, Susanne van Eeden, Steven T. Pals, and Marcel Spaargaren
Blood 2006; 107: 760-768.
[Abstract]
[Full text]
[PDF]
A model of oncogenic rearrangements: differences between chromosomal translocation mechanisms and simple double-strand break repair
- David M. Weinstock, Beth Elliott, and Maria Jasin
Blood 2006; 107: 777-780.
[Abstract]
[Full text]
[PDF]
Activating Notch1 mutations in mouse models of T-ALL
- Jennifer O'Neil, Jennifer Calvo, Keith McKenna, Veena Krishnamoorthy, Jon C. Aster, Craig H. Bassing, Frederick W. Alt, Michelle Kelliher, and A. Thomas Look
Blood 2006; 107: 781-785.
[Abstract]
[Full text]
[PDF]
The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor
- Isabelle S. Lucet, Emmanuelle Fantino, Michelle Styles, Rebecca Bamert, Onisha Patel, Sophie E. Broughton, Mark Walter, Christopher J. Burns, Herbert Treutlein, Andrew F. Wilks, and Jamie Rossjohn
Blood 2006; 107: 176-183.
[Abstract]
[Full text]
[PDF]
Synergistic antileukemic interactions between 2-medroxyestradiol (2-ME) and histone deacetylase inhibitors involve Akt down-regulation and oxidative stress
- Ning Gao, Mohamed Rahmani, Xianglin Shi, Paul Dent, and Steven Grant
Blood 2006; 107: 241-249.
[Abstract]
[Full text]
[PDF]
The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status
- Patricia Pérez-Galán, Gaël Roué, Neus Villamor, Emili Montserrat, Elias Campo, and Dolors Colomer
Blood 2006; 107: 257-264.
[Abstract]
[Full text]
[PDF]
Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain
- Florian Heidel, Fian K. Solem, Frank Breitenbuecher, Daniel B. Lipka, Stefan Kasper, M. H. Thiede, Christian Brandts, Hubert Serve, Johannes Roesel, Francis Giles, Eric Feldman, Gerhard Ehninger, Gary J. Schiller, Stephen Nimer, Richard M. Stone, Yanfeng Wang, Thomas Kindler, Pamela S. Cohen, Christoph Huber, and Thomas Fischer
Blood 2006; 107: 293-300.
[Abstract]
[Full text]
[PDF]
|
|
